Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022
Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022

Kalpit Patel Maintained (ALLO) at Strong Buy with Decreased Target to $18 on, Sep 22nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-sep-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kalpit Patel of B. Riley Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $21 to $18 on, Sep 22nd, 2022.

Kalpit has made no other calls on ALLO in the last 4 months.



There are 5 other peers that have a rating on ALLO. Out of the 5 peers that are also analyzing ALLO, 2 agree with Kalpit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Dane Leone of "Raymond James" Downgraded from Buy to Hold on, Wednesday, August 10th, 2022
  • Jack Allen of "Baird" Initiated at Hold and Held Target at $11 on, Friday, June 3rd, 2022


These are the ratings of the 3 analyists that currently disagree with Kalpit


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $32 on, Wednesday, August 10th, 2022
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 10th, 2022
  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $32 on, Friday, July 15th, 2022

Publication Contributing Sources